Increase the reach of TB testing
Tuberculosis is preventable and curable, yet millions of people with TB do not have access to affordable diagnostic testing. Targeted testing of those most at risk for TB is critical to meet the goals of the WHO End TB Strategy, aimed at reducing TB deaths by 95% by 2035.
-
Introducing QIAreach QuantiFERON-TB
QIAreach QuantiFERON-TB reimagines TB infection testing, helping you expand access to TB testing in both centralized and decentralized settings. Built on the proven QuantiFERON-TB Gold Plus technology, the QIAreach QuantiFERON-TB Test is a portable solution that will complement QuantiFERON-TB Gold Plus. -
It’s time to test and treat TB everywhere
QIAGEN is committed to the idea that no one should be left behind in the fight to End TB. In collaboration with Ellume, we have developed an easy-to-use, affordable, accurate TB test that reimagines modern TB testing in a simple to use, automated format. -
Expanding access to the most vulnerable
Without combining active TB control and TB prevention, we will not progress toward TB eradication. QIAreach QFT will expand access to TB infection testing among the most vulnerable in low resource and high burden settings. -
Fighting the stigma of TB disease
Dr. Rosa Herrera contracted tuberculosis after sheltering from an earthquake in a crowded ER. She recovered from the disease, but struggled with the stigma that it carried. Now, Herrera is doing all she can to reach out and treat the hardest hit communities. -
Bridging the gap in TB testing
High cost and lack of infrastructure are key barriers for the implementation of TB infection testing in resource-limited settings. Our innovative, scalable IGRA solution will help to tackle these problems through provision of universal access to TB testing for high-risk groups.
-
Eradicating TB in hotspot regions
TB is often relegated as a sickness of impoverished segments of the global population. But TB’s true impact is universal – affecting both rich and poor. Learn how activists and medical experts from TB hotspots are facing and overcoming the challenges of combatting TB.
-
Introducing QIAreach QuantiFERON-TB
-
It’s time to test and treat TB everywhere
-
Expanding access to the most vulnerable
-
Fighting the stigma of TB disease
-
Bridging the gap in TB testing
-
Eradicating TB in hotspot regions
QIAreach QFT is now available in >100 high-burden countries
See how we can help provide universal access to TB testing by increasing access in high-burden, low-resource regions.
IGRA testing reimagined
The QIAreach QuantiFERON-TB Test is a decentralized, single-visit solution that brings access to TB testing where it’s needed most. It shares key features with the industry-leading QuantiFERON-TB Gold Plus test – but replaces the lab-based ELISA workflow with an innovative digital lateral flow assay.
Decentralized TB screening
QIAreach QFT is both a test for TB infection and helpful aid for diagnosing M. tuberculosis complex infection in sick patients. The QIAreach QFT Test requires only one visit, and it’s portable and easy to use. Now you can reach patients in decentralized settings and remote areas.
-
PortableNo cold chain required, all test equipment <1 kg -
No maintenanceNo eHub maintenance or calibration, easy cleaning and dust protection -
8 h battery lifeUninterrupted operation when external power is not available -
ScalableScalable from 1 to 8 samples, up to 24 samples per hour
-
Quick start guideThe QIAreach QFT test is easy to perform – use our quick start guide as a reference -
Software and user manualQIAreach QFT features integrated data management and optional software
QIAreach QuantiFERON-TB is intended for high TB-burden countries.